Sectors
PLYX
Polaryx Therapeutics, Inc. Common Stock
2.34
1 x 2.17
1 x 2.33
bid
ask
+
0.02
0.86%
09:51 AM
timesize
| Ytd | -93.31% | |
| 1y | -93.31% |
2.30
day range
2.34
2.01
52 week range
48.91
| Open | 2.31 | Prev Close | 2.32 | Low | 2.30 | High | 2.34 | Mkt Cap | 115.64M |
| Vol | 3.96K | Avg Vol | 204.01K | EPS | -0.20 | P/E | -11.90 | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 2.66 | 200-d Avg | 4.63 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 1.96M | ||
| Research and Development Expense | 679.00K | ||
| Selling, General and Administrative Expense | 1.28M | ||
| Operating Income | -1.96M | ||
| Net Income | -2.54M | ||
| Net Income Common Stock | -2.54M | ||
| Net Income Common Stock (USD) | -2.54M | ||
| Consolidated Income | -2.54M | ||
| Earnings per Basic Share | -0.05 | ||
| Earnings per Basic Share (USD) | -0.05 | ||
| Earnings per Diluted Share | -0.05 | ||
| Earning Before Interest & Taxes (EBIT) | -2.54M | ||
| Earning Before Interest & Taxes (USD) | -2.54M | ||
| Weighted Average Shares | 47.22M | ||
| Weighted Average Shares Diluted | 47.22M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.08M | ||
| Cash and Equivalents (USD) | 3.08M | ||
| Current Assets | 3.50M | ||
| Total Assets | 3.50M | ||
| Current Liabilities | 1.01M | ||
| Total Liabilities | 1.01M | ||
| Accumulated Retained Earnings (Deficit) | -102.18M | ||
| Shareholders Equity | 2.49M | ||
| Shareholders Equity (USD) | 2.49M | ||
| Trade and Non-Trade Payables | 948.00K | ||
| Cash Flow | |||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.06M | ||
| Net Cash Flow from Operations | -2.06M | ||
| Share Based Compensation | 467.00K | ||